ResMed (RMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $236.20 +0.68%
EPS Growth %: +5.1%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
PGR, OMID, ACI, More
EPS Growth %: +5.1%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
PGR, OMID, ACI, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman’s CEO Solomon says to watch political volatility around data centers
- BofA Securities Upgrades TIM S.A. (TIMB) to Neutral
- Netflix (NFLX) PT Lowered to $85 at KeyBanc
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
